Key result
Central microglial and astrocytic activation drives autonomic imbalance and adverse cardiovascular remodelling across heart diseases.
Why the study?
Although bidirectional communication between the brain and heart involves neuroimmune mechanisms, the contributions of glial responses in different brain regions to autonomic dysfunction and cardiovascular remodelling remain incompletely understood.
This narrative review integrates preclinical and mechanistic evidence on how microglial and astrocytic responses in autonomic brain regions contribute to autonomic dysfunction and cardiovascular remodelling across hypertension, myocardial infarction, and heart failure.
Brain-targeted therapies should not yet change practice; leaves open causal validation of glial-autonomic pathways in hypertension, MI, and HF.
Bidirectional communication between the brain and heart involves neuroimmune mechanisms, yet the contributions of glial responses in different brain regions to autonomic dysfunction and cardiovascular remodelling remain incompletely understood. This narrative review integrates evidence on microglial and astrocytic regulation of the brain–heart axis, focusing on autonomic brain regions and their molecular responses to cardiovascular injury. We examine how inflammatory, humoral and neural signals engage glial cells and influence neurovascular integrity, neurotransmitter homeostasis and neuronal excitability. Particular attention is given to angiotensin II signalling, purinergic pathways, NLRP3 inflammasome activation and oxidative stress as mechanisms linking glial responses to altered sympathetic–vagal balance. Across hypertension, myocardial infarction and heart failure, studies report glial alterations in multiple brain regions, with selected experiments supporting contributions to autonomic regulation and cardiovascular outcomes. However, regional involvement does not by itself establish distinct glial states or region-specific functions. We therefore distinguish regional distribution, molecular/cellular heterogeneity and causal function within a defined region, and propose a framework for testing how anatomical context, cellular state and disease stage may influence glial effects. The proposed feedback between cardiac injury, glial responses, autonomic dysfunction and cardiovascular remodelling represents an integration of evidence for individual links, rather than a directly demonstrated, fully glia-mediated causal loop. Current limitations include predominantly preclinical evidence, insufficient cell-specific causal validation and limited human translation. Integrating single-cell and spatial profiling with targeted perturbation and concurrent neural and cardiac phenotyping may clarify these relationships and inform the development of glia-directed interventions.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a review in Hypertension, myocardial infarction, and heart failure. Glial-mediated neuroimmune regulation (microglial and astrocytic responses) was evaluated on Autonomic dysfunction and cardiovascular remodelling. Microglial and astrocytic responses in autonomic brain regions contribute to sympathetic–vagal imbalance and cardiovascular remodelling across hypertension, myocardial infarction, and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: